Advisor Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22,768
| Closed | -$2.26M | – | 662 |
|
|
2019
Q3 | $2.26M | Buy |
22,768
+2,004
| +10% | +$190K | 0.27% | 76 |
|
|
2019
Q2 | $1.92M | Buy |
20,764
+1,779
| +9% | +$169K | 0.23% | 83 |
|
|
2019
Q1 | $1.79M | Buy |
18,985
+7,064
| +59% | +$618K | 0.23% | 84 |
|
|
2018
Q4 | $764K | Sell |
11,921
-331
| -3% | -$24.4K | 0.12% | 187 |
|
|
2018
Q3 | $1.1M | Buy |
12,252
+3,983
| +48% | +$352K | 0.15% | 136 |
|
|
2018
Q2 | $657K | Sell |
8,269
-2,547
| -24% | -$211K | 0.11% | 209 |
|
|
2018
Q1 | $965K | Sell |
10,816
-4,199
| -28% | -$403K | 0.18% | 126 |
|
|
2017
Q4 | $1.54M | Buy |
15,015
+1,163
| +8% | +$131K | 0.28% | 78 |
|
|
2017
Q3 | $2.02M | Buy |
13,852
+1,051
| +8% | +$143K | 0.4% | 49 |
|
|
2017
Q2 | $1.66M | Buy |
12,801
+514
| +4% | +$63K | 0.39% | 56 |
|
|
2017
Q1 | $1.53M | Buy |
12,287
+220
| +2% | +$26.3K | 0.41% | 53 |
|
|
2016
Q4 | $1.4M | Buy |
12,067
+1,972
| +20% | +$220K | 0.42% | 55 |
|
|
2016
Q3 | $1.05M | Sell |
10,095
-120
| -1% | -$13K | 0.35% | 73 |
|
|
2016
Q2 | $1.01M | Sell |
10,215
-506
| -5% | -$52.3K | 0.35% | 76 |
|
|
2016
Q1 | $1.07M | Sell |
10,721
-1,139
| -10% | -$117K | 0.4% | 64 |
|
|
2015
Q4 | $1.42M | Sell |
11,860
-394
| -3% | -$45.6K | 0.48% | 57 |
|
|
2015
Q3 | $1.33M | Sell |
12,254
-369
| -3% | -$45.8K | 0.56% | 44 |
|
|
2015
Q2 | $1.46M | Buy |
12,623
+2,700
| +27% | +$309K | 0.56% | 45 |
|
|
2015
Q1 | $1.14M | Sell |
9,923
-191
| -2% | -$22.8K | 0.49% | 53 |
|
|
2014
Q4 | $1.13M | Buy |
10,114
+821
| +9% | +$86.6K | 0.5% | 52 |
|
|
2014
Q3 | $881K | Sell |
9,293
-20
| -0.2% | -$1.8K | 0.5% | 53 |
|
|
2014
Q2 | $800K | Buy |
9,313
+1,481
| +19% | +$113K | 0.39% | 71 |
|
|
2014
Q1 | $547K | Sell |
7,832
-184
| -2% | -$14.6K | 0.3% | 109 |
|
|
2013
Q4 | $677K | Buy |
8,016
+1,068
| +15% | +$84.5K | 0.39% | 82 |
|
|
2013
Q3 | $536K | Buy |
6,948
+120
| +2% | +$8.41K | 0.38% | 88 |
|
|
2013
Q2 | $399K | Buy |
+6,828
| New | +$411K | 0.33% | 103 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Advisor Partners's CELG Position: Q4 2019 in Review
Advisor Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,768 shares — an estimated $2.26M sold.
Advisor Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.26M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Advisor Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Advisor Partners sold 22,768 Celgene Corp shares in Q4 2019, an estimated $2.26M.
- Advisor Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Advisor Partners's Celgene Corp position peaked at $2.26M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Advisor Partners's 13F filing for Q4 2019, filed 24 Jan 2020.